Navigation Links
Keryx Biopharmaceuticals to Present at William Blair & Company Small-Cap Growth Stock Conference
Date:10/1/2007

NEW YORK, Oct. 1 /PRNewswire-FirstCall/ -- Keryx Biopharmaceuticals, Inc. (Nasdaq: KERX) today announced that I. Craig Henderson, MD, the Company's President, will present an overview of the Company's cancer pipeline at the upcoming William Blair & Company Small-Cap Growth Stock Conference in New York City. Dr. Henderson's presentation will take place on Wednesday, October 3rd at 12:30 pm ET.

Dr. Henderson's presentation will be webcast live and will be accessible from the Investor Information page of the Company's Website at http://investors.keryx.com. An archived version of the webcast will be available following the conclusion of the live presentation.

ABOUT KERYX BIOPHARMACEUTICALS, INC.

Keryx Biopharmaceuticals, Inc. is focused on the acquisition, development and commercialization of medically important, novel pharmaceutical products for the treatment of life-threatening diseases, including diabetes and cancer. Keryx's lead compound under development is Sulonex(TM) (sulodexide), previously referred to as KRX-101, a first-in-class, oral heparinoid compound for the treatment of diabetic nephropathy, a life-threatening kidney disease caused by diabetes. Sulonex is in a pivotal Phase III and Phase IV clinical program under a Special Protocol Assessment with the Food & Drug Administration. Additionally, Keryx is developing Zerenex(TM), an oral, iron- based compound that has the capacity to bind phosphate and form non-absorbable complexes. Zerenex is currently in Phase II clinical development for the treatment of hyperphosphatemia (elevated serum phosphorous levels) in patients with end-stage renal disease. Keryx is also developing clinical-stage
'/>"/>

SOURCE Keryx Biopharmaceuticals, Inc.
Copyright©2007 PR Newswire.
All rights reserved

1

GOOD

Page: 1 2

Related medicine technology :

1. Keryx Biopharmaceuticals, Inc. Announces Positive Phase I and Phase II Data on KRX-0401 in Patients with Relapsed/Refractory Multiple Myeloma and Waldenstroms Macroglobulinemia
2. Keryx Biopharmaceuticals, Inc. Announces Poster Presentations Highlighting Mechanism of Action and Clinical Activity of Sulonex(TM) (sulodexide oral gelcap) at the Upcoming American Diabetes Association 67th Scientific Sessions in Chicago, Illinois
3. AEterna Zentaris Partner Keryx Presents Phase 1 and Phase 2 Results for Anti-Cancer Compound Perifosine at ASCO Meeting
4. Inspiration Biopharmaceuticals Presents Data From Hemophilia Program at International Society On Thrombosis and Haemostasis (ISTH) Annual Meeting
5. Accentia Biopharmaceuticals Announces Favorable Interim Blinded Data on SinuNase in Its Fast-Tracked Pivotal Phase 3 Clinical Trial for Chronic Sinusitis
6. Accentia Biopharmaceuticals Scientific Presentations Demonstrate Increasing Acceptance of Fungal Etiology of Chronic Sinusitis at the Annual Meeting of the American Academy of Allergy, Asthma, and Immunology
7. The Past, Present and Future of HLA Typing
8. Sygnis Pharma AG announces date for presentation of clinical results
9. Phase 3 Results for Dabigatran Etexilate, an Investigational Oral Anticoagulant, Presented Today at the XXIst Congress of the International Society on Thrombosis and Haemostasis
10. Neose Announces Presentation of Positive Preclinical Data on GlycoPEGylated Factor VIIa at the XXI Congress of the International Society on Thrombosis and Haemostasis
11. Halozyme Therapeutics Enhanze Technology Large Protein Molecule Therapeutic Clinical Trial Results Presented at the 34th Annual Meeting of the Controlled Release Society

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/30/2009)...Newswire/ -- MedPro Imaging, a premium provider of...owcase leading ultrasound solutions including the ...mium Edition during the company,s debut at the 95t...ence, being held in Chicago November 29 - Dec. 3, ...ltrasound products and services in 17 countries, p...
(Date:11/30/2009)... Nov. 30 Decision Resources, one o...focusing on pharmaceutical and healthcare issues, ...n Russia will grow nine percent annually over the ... 2013. This growth will be driven mainly by increa...d use of more-expensive therapies like pegylated i...
(Date:11/30/2009)...PRNewswire/ -- Stemline Therapeutics, Inc., a priv...eading developer of oncology compounds directed to...rsity of Texas M.D. Anderson Cancer Center (Housto...ollaboration. As part of this collaboration, M.D. ... trial of SL-401 in patients with acute myeloid le...
Breaking Medicine Technology:MedPro Imaging to Showcase Leading New and Refurbished Ultrasound Solutions at RSNA 2Russia's Hepatitis C Virus Drug Market Will Grow Nine Percent Annually, Reaching $327 Million by 2013 2Russia's Hepatitis C Virus Drug Market Will Grow Nine Percent Annually, Reaching $327 Million by 2013 3Stemline Therapeutics Expands Clinical Oncology Program Directed at Cancer Stem Cells With Addition of M.D. Anderson Cancer Center 2Backyard Raccoon Latrines Harbor Hidden Dangers 54549 1Backyard Raccoon Latrines Harbor Hidden Dangers 54549 2Backyard Raccoon Latrines Harbor Hidden Dangers 54549 3Studies do not support unhealthful relation between animal foods and breast cancer 54547 1Studies do not support unhealthful relation between animal foods and breast cancer 54547 2UC Davis challenge produces a better air conditioner 9578 1UC Davis challenge produces a better air conditioner 9578 2
(Date:11/30/2009)... pet owner knows the enormous joy and comfort that...es. Most pets are considered important members of ... body of research now documents the value of the h...e, mental illness, physical impairment, dementia, ...of incarcerated youth and adults. , In two artic...
(Date:11/30/2009)...ravy and dessert at the holiday table are even les...ght. According to a new research report recently a...w.fasebj.org ), a diet that is high in fat and in ...ause our bodies to store too much fat. This means ...ready difficult task of converting high-fat and hi...
(Date:11/30/2009)... over time, so do knees, internal injuries, study ...ews) -- If you,re a middle-age weekend warrior who... take note: A new study suggests that high levels ...ee damage that could lead to osteoarthritis. , ...le-age people who showed no symptoms and had a hea...
(Date:11/30/2009)... Colo., Nov. 30 Baxa Corporation i...g what "culture of safety" means in today,s pharma..., "Creating a Culture of Safety in Pharmacy ," fe...ussing their experiences with culture of safety, w...acy and the role of technology in enabling or inhi...
(Date:11/30/2009)..., Nov. 30 Reportlinker.com announc...in its catalogue: ,, Gene Therapy - Worldwide ...://www.reportlinker.com/p0164218/Gene-Therapy---Wo..., Gene therapy promises to be one of the most im...cant achievements for curing disease have been ach...
Breaking Medicine News(10 mins):Health News:The therapeutic benefits of the human-animal bond 2Health News:Western diets turn on fat genes 2Health News:Lots of Exercise in Midlife May Lead to Osteoarthritis 2Health News:Lots of Exercise in Midlife May Lead to Osteoarthritis 3Health News:Baxa to Sponsor ASHP Midday Symposium: Creating a Culture of Safety in Pharmacy, A Panel Discussion on Lessons Learned 2Health News:Baxa to Sponsor ASHP Midday Symposium: Creating a Culture of Safety in Pharmacy, A Panel Discussion on Lessons Learned 3Health News:Reportlinker Adds Gene Therapy - Worldwide Market Challenges & Opportunities 2Health News:Reportlinker Adds Gene Therapy - Worldwide Market Challenges & Opportunities 3Health News:Reportlinker Adds Gene Therapy - Worldwide Market Challenges & Opportunities 4Health News:Reportlinker Adds Gene Therapy - Worldwide Market Challenges & Opportunities 5
...loped and,produced HealthSmart television series h... its very first year on the air. The idea for the,...ea,s largest health,insurer, as an innovative way ...casts the series from their new public,media cente...
... prostate cancer, researchers say , , FRID...dding vitamin E or the tomato nutrient lycopene to...may need to think again. , According to a new stud...that are in line with two other recent publication...
...troit,s most prominent artists will donate origina...ual "ART WORKS FOR LIFE." This exciting event,will...at The Ritz-Carlton,Dearborn to benefit the Midwes...sh bar, valet or self parking,and live musical ent...
... and great differences among countries. This is w...use previously collected samples from biobanks in ...emely complicated to carry out major international...searchers, put forward a pioneering solution: a se...
...irectors of Abbott today declared a quarterly comm...he 335th consecutive quarterly dividend to be paid...e Nov. 15, 2007, to,shareholders of record at the ...ment, manufacture and marketing of pharmaceuticals...
...from the Detroit Metro Air Traffic Control Tower h...t Court regarding a nearly three-year-old,problem ...lers, including,several who have missed significan...eral,Aviation Administration failed to properly re...
Other Medicine News:Health News:Locally Produced Health Series Nominated for Emmy in its First Year 2Health News:Tomato Diet Can't Guarantee Prostate Health: Study 2Health News:Tomato Diet Can't Guarantee Prostate Health: Study 3Health News:Tomato Diet Can't Guarantee Prostate Health: Study 4Health News:Long-awaited international ethical guidelines for biobank researchers 2Health News:Detroit Metro Tower Air Traffic Controllers File Lawsuit Alleging Improper Mold Removal and Health Effects 2
...Anesthesia Monitor (AM) is a multiparameter monito...for routine to the most demanding anesthesia appli...s, you can choose the set of parameters that best ...s evolve, the modularity of the S/5 AM allows you ...
...om, ,The Cardiocap II is a cost-effective solutio...ing for induction rooms, operating rooms and post ...le in 4 compact models, all providing the basic ha... built-in gas measurement and breath-by-breath ana...
Anesthetists Precordial Kit
Precordial Chestpieces
Medicine Products: